Ucku, DuyguArmutlu, AyseCipe, FundaErsoy, Gizem ZenginKarakaya, Afak DururArikan, Cigdem2024-05-192024-05-1920231077-41141536-3678https://doi.org10.1097/MPH.0000000000002661https://hdl.handle.net/20.500.12713/4633Adenosine deaminase (ADA) deficiency is one of the most prevalent forms of severe combined immunodeficiency and results in the accumulation of toxic substrates which creates a systemic metabolic disease. It predisposes patients to the development of malignancies, most commonly lymphoma. We report an 8-month-old infant with ADA deficient severe combined immunodeficiency who developed progressive liver dysfunction and hepatocellular carcinoma after successful hematopoietic stem cell transplantation. This is the first case report of an ADA-deficient patient who presented with hepatocellular carcinoma and gives an insight into the complex etiology that can lie behind liver dysfunction in these patients.eninfo:eu-repo/semantics/closedAccessAdenosine DeaminaseSevere Combined ImmunodeficiencyHematopoietic Stem Cell TransplantationHepatocellular CarcinomaLiver TransplantationArticle45528528937027238WOS:0010177823000122-s2.0-85163807628N/A10.1097/MPH.0000000000002661Q3